Immunotherapy for Early-Stage Triple-Negative Breast Cancer | NEJM
Early-stage triple-negative breast cancers, which lack expression of three proteins (estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2), have long been defined …